Top Harvest Capital

Youlify is a company that specializes in AI-driven solutions for medical billing and revenue cycle management. Its platform is designed to assist medical practices in improving their billing and collections processes by offering an AI-powered onboarding approach that enhances payment efficiency. Additionally, Youlify provides tools for investigating denied claims and delivers real-time financial insights and analytics. This enables healthcare providers to appeal denied claims effectively, increasing their chances of successful resolution. Overall, Youlify focuses on leveraging artificial intelligence to optimize financial operations within the medical sector.

Founded in 2016, Voxel51 specializes in computer vision and machine learning analytics for video and image understanding. The company enables AI builders to simplify workflows by transforming raw footage into actionable intelligence, facilitating exploration, visualization, curation, and testing of datasets alongside models to build production-ready visual AI systems.

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Bioptimus develops a universal AI foundation model that connects biological data across different scales, from molecules to entire organisms. This enables clients to derive actionable insights and accelerate biomedical innovation.

Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.

Inato provides an AI-powered platform that automates the collection, structuring, and analysis of data used to launch clinical trials for life sciences companies. Founded in 2016 and headquartered in Paris, with offices in New York and London, the company connects pharmaceutical developers with a global network of research sites through a clinical trial marketplace, facilitating enrollment planning and ongoing site support. By cross-checking data sources and deriving actionable insights, Inato aims to reduce drug development costs and shorten timelines, helping therapies reach patients faster and more efficiently.

Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals.

Rembrand is an advertising agency specializing in a comprehensive range of marketing services, including brand strategy, campaign management, and social media marketing. The company offers digital marketing solutions such as content marketing, newsletter, display advertising, and employer branding. Additionally, Rembrand has developed a programmatic product placement platform that utilizes generative AI to enhance videos with virtual product placements, allowing brands to connect seamlessly with creators to scale their marketing efforts. This innovative approach to monetizing videos without interruptive ads positions Rembrand as a forward-thinking player in the advertising landscape.

Vectara offers a generative AI platform for embedding AI features into applications. Its serverless Retrieval Augmented Generation API enables businesses to integrate conversational AI and question-answering securely, with minimal hallucination, explainable results, and real-time updatability.

Founded in 2016, Voxel51 specializes in computer vision and machine learning analytics for video and image understanding. The company enables AI builders to simplify workflows by transforming raw footage into actionable intelligence, facilitating exploration, visualization, curation, and testing of datasets alongside models to build production-ready visual AI systems.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.

Kinetix enables users to express themselves in the Metaverse by offering AI-powered, no-code tools for creating 3D animations.

Mindmesh is a software developer focused on enhancing communication and efficiency for product-oriented teams and managers. The company provides a knowledge base tool that addresses challenges related to context switching and information fragmentation. Its innovative interface centralizes actionable insights from various sources, including notes, tasks, and calendars, while integrating seamlessly with popular team collaboration tools such as Slack, Gmail, Calendar, Jira, and Drive. By facilitating the quick creation of concise documentation and enabling the search for dispersed knowledge, Mindmesh aims to foster collaboration among employees, allowing them to easily connect and access information regardless of their current tasks or locations.

MEDiC is a biotechnology company based in the San Francisco Bay Area. It specializes in cancer drug target discovery using its proprietary CRISPR functional genomics platform, focusing on 3D tumor models.

Mantium is a secure cloud-based data platform that facilitates software developers in accessing, transforming, and enriching data using large language models while ensuring data privacy and security. The platform offers a no-code solution that streamlines workflows through automated data preparation, which includes capabilities for transforming, cleaning, and enriching data from diverse sources. By enabling the creation of various datasets and managing data pipelines and infrastructure, Mantium accelerates the artificial intelligence journey for its clients, effectively supporting them in the initial stages of the AI development process.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.